New Jersey S 680: Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2022-01-11)

State: New Jersey · Session: 220 · Bill: S 680

Subjects: HEALTH INSUR, PHARMACEUTIC

Sponsors: Bramnick, Jon M., Bucco, Anthony M.

View New Jersey S 680 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.